Researchers in Taiwan recently completed a pilot study using low-intensity focused ultrasound neuromodulation to treat patients with drug-resistant epilepsy.
The procedure was safe, well-tolerated, and accurately targeted the seizure onset zone for each individual participant.
Philip C. Keevil, MA (Oxon), MBA, FRSA, served as founder and chairman of the UK Focused Ultrasound Foundation and an advisor to the US-based Foundation.
He leaves a valued legacy for advancing focused ultrasound in the UK, and our thoughts are with his family at this time.
A preclinical study tested a new strategy for treating glioblastoma by using focused ultrasound to deliver microRNA-containing nanoparticles to the brain.
In research models, the treatment reduced tumor growth and extended survival.
“I hope that even with my tiny piece of participation in this, that it helps to expand the potential for this technology. The applications are seemingly endless…and I’m excited for the future of focused ultrasound.”
‒ Keith Merker, after taking part in in a focused ultrasound clinical trial for glioblastoma